United States · FDA National Drug Code directory
Loperamide Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51660-123_0ea718d4-6b42-b9ee-e063-6294a90a8111
- Product NDC
- 51660-123
- Form
- TABLET
- Composition / generic term
- Loperamide Hydrochloride
- Labeler
- Ohm Laboratories Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19930201
- Source listing expiry
- 20261231
Source-listed ingredients
- LOPERAMIDE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (51660-123-06) / 6 TABLET in 1 BLISTER PACK · 51660-123-06
- 2 BLISTER PACK in 1 CARTON (51660-123-12) / 6 TABLET in 1 BLISTER PACK · 51660-123-12
- 4 BLISTER PACK in 1 CARTON (51660-123-24) / 6 TABLET in 1 BLISTER PACK · 51660-123-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →